An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China
نویسندگان
چکیده
منابع مشابه
An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China.
INTRODUCTION Cervical cancer screening and existing health insurance schemes in China fall short of reaching women with prevention and treatment services, especially in rural areas where the disease burden is greatest. We conducted an extended cost-effectiveness analysis (ECEA) to evaluate public financing of HPV vaccination to prevent cervical cancer, adding new dimensions to conventional cost...
متن کاملAssessing the effectiveness of human papillomavirus (HPV) vaccination to prevent cervical cancer: perspectives from Germany.
For approximately 2 years now, cervical cancer has been “converted” from an oncological disease to an infectious disease, which is said to be preventable by and large by two vaccines licensed in many countries. However, human papillomavirus (HPV) vaccines differ from existing others, as the former target a condition which only in a minute fraction of infections will lead to serious consequences...
متن کاملProgrammatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
BACKGROUND Cervical cancer remains an important health problem even in countries with effective cervical screening programs. HPV vaccines offer great potential for primary prevention of cervical cancer and other HPV-related diseases. PERSPECTIVES Eventual implementation of an HPV vaccination program raises several key issues, including universal vs. targeted vaccinations, the age and gender o...
متن کاملRe: Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.
Goldhaber-Fiebert et al. ( 1 ) presented a convincing model for the natural history of cervical cancer. The results of this study should be considered by all policy makers in taking decisions about the preventive strategies for cervical cancer. The evaluation of this model was made by comparing the observed incidence curve by age of cervical cancer onset with the predicted incidence curve. In i...
متن کاملCost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.
BACKGROUND The availability of human papillomavirus (HPV) DNA testing and vaccination against HPV types 16 and 18 (HPV-16,18) motivates questions about the cost-effectiveness of cervical cancer prevention in the United States for unvaccinated older women and for girls eligible for vaccination. METHODS An empirically calibrated model was used to assess the quality-adjusted life years (QALYs), ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Vaccine
سال: 2015
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2015.02.052